3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan

Details 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan

1997-06-23

1998-09-29

Krass, Frederick

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514 23, 514 42, 514676, 536 291, 564 1, 564444, 568305, 436501, 436 2, 436 14, 436 15, 436 86, 436 87, 436111, 436128, 436815, G01N 3353

Patent

active

058146644

ABSTRACT:
The present invention relates to advanced glycosylation endproducts, and particularly to the use of novel cyclopentenone aminoreductones, 3-alkylamino-2 -hydroxy-4-hydroxymethyl-2-cyclopenten-1-ones. Such AGEs can be used in various diagnostic and therapeutic methods.

REFERENCES:
patent: 5668653 (1997-09-01), Ulrich et al.

Affiliated with

Also associated with

Rating

3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-686757